Results 31 to 40 of about 734,103 (389)

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

open access: yesScientific Reports, 2017
Chondrosarcoma (CS) is a rare cancer, but it is the second most common primary malignant bone tumor and highly resistant to conventional chemotherapy and radiotherapy.
Pei Liu   +4 more
doaj   +1 more source

Intrapelvic melanocytic schwannoma resection with computer-assisted navigation

open access: yesRadiology Case Reports, 2020
Melanocytic schwannoma is a rare nerve tumor characterized by melanin-producing neoplastic Schwann cells. Wide surgical resection is the management of choice for this tumor; however, anatomical location and proximity to nerve roots can make locating this
Caroline A. Gerhardt, BS   +4 more
doaj   +1 more source

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas

open access: yesJournal of Hematology & Oncology, 2021
Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown.
S. Verbeke   +7 more
doaj   +1 more source

Ewing Sarcoma

open access: yesSarcomas, 2019
Ewing sarcoma is a cancerous tumor that occurs in bones or soft tissues, such as cartilage or nerves. There are several types of Ewing sarcoma, including Ewing sarcoma of bone, extraosseous Ewing sarcoma, peripheral primitive neuroectodermal tumor (pPNET)
W. Alperstein, M. Trucco
semanticscholar   +1 more source

The reverse protraction factor in the induction of bone sarcomas in radium-224 patients [PDF]

open access: yes, 1990
More than 50 bone sarcomas have occurred among a collective of about 800 patients who had been injected in Germany after World War II with large activities of radium-224 for the intended treatment of bone tuberculosis and ankylosing spondylitis.^In an ...
Chmelevsky, D.   +3 more
core   +1 more source

Cutaneous sarcomas [PDF]

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2017
SummaryCutaneous sarcomas comprise a heterogeneous group of mesenchymal spindle cell tumors of the dermis and subcutis, one of the best‐known entities being dermatofibrosarcoma protuberans. Other sarcomas addressed in this review include atypical fibroxanthoma, cutaneous undifferentiated pleomorphic sarcoma, leiomyosarcoma, liposarcoma, and ...
Judith, Kohlmeyer   +2 more
openaire   +2 more sources

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

open access: yesAnnals of Oncology, 2019
Background NETSARC (netsarc.org) is a network of 26 sarcoma reference centers with specialized multidisciplinary tumor boards (MDTB) aiming to improve the outcome of sarcoma patients. Since 2010, presentation to an MDTB and expert pathological review are
J. Blay   +52 more
semanticscholar   +1 more source

Histiocytic Sarcoma

open access: yesDefinitions, 2020
Histiocytic sarcoma, a rare malignant neoplasm showing morphologic and immunophenotypic features of histiocytes, is characterized typically by extranodal presentation and a dismal clinical course, particularly in patients with disseminated disease.
Xiaohua Qian
semanticscholar   +1 more source

Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy

open access: yesBMC Cancer, 2017
Background Myoepithelial carcinoma of soft tissue is a rare, malignant neoplasm that is morphologically and immunophenotypically similar to its counterpart in salivary gland.
Timothy M. Hoggard   +9 more
doaj   +1 more source

Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma. a case report [PDF]

open access: yes, 2017
Endometriosis is a chronic disease that affects women of reproductive age. Malignant transformation in endometriosis is considered to be an unusual event, only occurring in 0.7-0.1% of cases.
Caserta, D.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy